Overview of Soluvit N

Property	Description
Active ingredients	Nine water-soluble vitamins (B-complex and Vitamin C)
Form	Lyophilised powder for solution for infusion/injection
Pharmacological class	Multivitamin / Water-soluble vitamins supplement
General purpose	Maintenance of nutritional status during specialized feeding
Origin	Primarily synthetic

Soluvit N: Definition and Pharmacological Classification

Soluvit N is a specialized pharmaceutical preparation classified within the high-level pharmacological class of a multivitamin and is designated as a supplement of water-soluble vitamins. This particular product is clinically recognized for its reliable use as a key component in Total Parenteral Nutrition (TPN) regimens globally. It is a combination product containing nine distinct essential vitamins, utilized as a foundational component in comprehensive intravenous feeding. This product is strictly reserved for parenteral use, meaning it is administered directly into the bloodstream, a defining feature that distinguishes it from over-the-counter oral nutritional supplements.

Composition and Pharmaceutical Form of Soluvit N

The composition of Soluvit N includes the B-complex group and Vitamin C. Its active ingredients [INN] are Thiamine, Riboflavin, Nicotinamide, Pyridoxine, Pantothenic acid, Ascorbic acid, Biotin, Folic acid, and Cyanocobalamin. The drug is supplied in the specialized dosage form of a sterile lyophilised powder for solution for infusion/injection. The lyophilized powder must be reconstituted with a suitable sterile base/vehicle, such as water for injections or glucose solution, prior to its intravenous route of administration. This sterile, powder-based presentation is crucial for its safe incorporation into large-volume intravenous fluids.

General Purpose: Why Soluvit N is Administered

The primary general purpose of Soluvit N is to maintain or replete the body’s necessary nutritional status of these micronutrients when a patient cannot meet their daily requirements through the digestive system. The administration of this multivitamin preparation is essential for protecting patients against deficiency-related complications when receiving total Intravenous nutrition (IV nutrition). By ensuring the direct nutrient supply of these cofactors, Soluvit N sustains core cellular and metabolic function in critically ill or non-orally feeding patients, such as those recovering from major surgery or experiencing severe malabsorption.

Regulatory References

What side effects are possible with Soluvit N?

Possible Side Effects and Safety Information

Soluvit N's safety profile focuses primarily on documented risks related to the intravenous administration of water-soluble vitamins and specific patient constraints, as structured in regulatory documents. The frequency of most adverse reactions is often categorized as Not known (cannot be estimated from the available data) in official labeling for this specialized product.

Documented Adverse Reactions by System-Organ Class

The following types of adverse reactions have been documented in regulatory sources and classified by the affected system:

Immune System Disorders: The risk of hypersensitivity reactions, including severe anaphylactic shock, is a documented constraint, particularly linked to components like Thiamine (Vitamin B1) or Folic acid.
Skin and Subcutaneous Tissue Disorders: Reactions such as flushing, pruritus (itching), erythema, and rash have been reported.
Nervous System Disorders: Possible effects include headache and dizziness.
Gastrointestinal Disorders: Effects such as nausea and vomiting may occur.

Population-Specific Safety Constraints

Specific safety considerations are defined for certain patient populations and pre-existing conditions:

Contraindications: The product is restricted in patients with a known history of hypervitaminosis of any component and those with hypersensitivity to the active substances or excipients.
Megaloblastic Anemia: The Folic acid content may mask the symptoms of underlying pernicious anemia (Vitamin B12 deficiency), a key safety note.
Diagnostic Interference: The presence of Biotin in the formulation is officially documented to potentially interfere with certain laboratory tests that utilize biotin/streptavidin interaction.

Some adverse effects, such as chills, shivering, or allergic responses, have been reported to occur immediately or soon after the infusion is administered. The profile also includes high-level notes regarding Pyridoxine (Vitamin B6) reducing the effect of levodopa and Folic acid interacting with phenytoin.

Overdose and Emergency Response

The official regulatory profile indicates that adverse effects associated with Soluvit N overdose are generally unlikely when the product is administered as recommended. Manifestations of overdose are typically reported only with the administration of extremely high parenteral doses of water-soluble vitamins.

Documented Overdose Manifestations

Overdose may present with expected CNS reactions, including headache, dizziness, and agitation. Dermatological reactions, such as flushing, erythema, and pruritus, may also be observed. Severe allergic reactions, including anaphylaxis, are listed as a potential serious outcome requiring intervention. The risk of hypervitaminosis A and D should also be considered if the product is reconstituted with certain solutions containing fat-soluble vitamins. The risk of biotin interference with laboratory test results is noted as being higher in children and patients with renal impairment at higher doses.

When to Seek Help and Required Actions

Upon suspected overdose, further administration of the product must be discontinued immediately. If a severe allergic reaction is suspected, the infusion should be stopped immediately. Management consists of initiating symptomatic and supportive therapy as appropriate, as no specific treatment is needed for the overdosage of the water-soluble vitamin components. The official mandate is to contact the Poison Information Centre for management information in cases of suspected overdose.

Therapeutic Uses of Soluvit N

What Soluvit N Treats: Main Uses and Benefits

Soluvit N is commonly used as a necessary component of intravenous nutritional support for patients who cannot receive adequate sustenance through oral or gastrointestinal feeding. The primary indication is to serve as a supplement in intravenous nutrition, and is applied in addressing the need for water-soluble vitamins in adults, children, infants, and neonates, who require this specific supportive care.

The foundational support assists in addressing symptoms related to systemic imbalance by supplying the B-complex group and Vitamin C when the body is under physical stress from illness or recent surgery. The core benefit plays a supportive role in addressing the risk of deficiency sequelae, helping to maintain a sense of stability and contributing to the maintenance of functional stability in situations where the intake of nutrients is otherwise highly restricted or inadequate. This is relevant in contexts involving: prolonged parenteral nutrition, severe malabsorption syndromes, and conditions requiring bowel rest.

“This foundational support helps patients cope more steadily with symptom fluctuations by working to maintain a consistent micronutrient supply during periods of IV dependence.”

Quick Fact: Support for Deficiency Risk

Soluvit N helps manage the risk of micronutrient depletion, which, if left unaddressed, may lead to symptoms that interfere with functional stability, such as those impacting nerve health and wound recovery.

Regulatory References

Medsafe Product Information

Eligibility and Restrictions for Use

Who can and cannot use Soluvit N?

Eligibility for Soluvit N is strictly defined by official regulatory documentation, primarily based on contraindications and the medicine's role as a daily supplement.

Contraindicated Populations (Must Not Use)

Patients with known hypersensitivity or allergy to any component of Soluvit N, such as thiamine or methyl parahydroxybenzoate.

Age-Group Eligibility

Soluvit N is approved for use across all major age groups requiring intravenous nutrition, including adults, adolescents, children, infants, and neonates.
No specific data is available for use in older adults, which may necessitate individualized assessment.

Condition-Based Restrictions

The product is not sufficient to correct severe vitamin deficiency states; its use is strictly limited to meeting daily maintenance requirements.
Use requires caution in patients with renal impairment or pernicious anaemia.
- Caution in renal impairment is due to the potential for the biotin component to interfere with certain clinical laboratory tests.
- Caution in pernicious anaemia is due to the risk of the folic acid component obscuring the diagnosis.

Pregnancy and Lactation Status

Use is generally permitted during both pregnancy and breastfeeding, though requirements for vitamins may be altered and should be assessed.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Soluvit N is structured around the specific documented effects of its water-soluble vitamin components on other medications and administration procedures, as detailed in regulatory sources.

Official Interaction Statements

Interacting Substance	Officially Documented Interaction
Levodopa	The Pyridoxine component can reduce the therapeutic effect of Levodopa.
Phenytoin	The Folic acid component may lower the serum concentrations of Phenytoin.
Methotrexate	Co-administration may reduce the efficacy of Methotrexate.
Chloramphenicol	May diminish the expected hematological response to Cyanocobalamin.

Administration Constraints and Incompatibilities

Soluvit N must only be mixed with other medicinal products for which compatibility and stability have been documented by the manufacturer or regulatory bodies. A key restriction is the documented physical incompatibility with certain intravenous vehicles. Other medicines should not be added to Soluvit N when dissolved in specific lipid emulsions (such as Intralipid, SMOFlipid, or Vitalipid N) due to the risk of degradation or other physical issues.

Interaction with Laboratory Tests

Biotin may interfere with laboratory tests that rely on biotin/streptavidin interaction, potentially leading to falsely decreased or increased results. The official label notes that the risk of this interference is higher in children and in patients with renal impairment.

Mechanism of Action

Soluvit N is a parenteral micronutrient mixture containing water-soluble vitamins that act as essential enzyme cofactors and metabolic substrates. The constituent B vitamins and Vitamin C are selectively transported across the plasma membranes of hepatocytes and renal tubular cells, primarily via SLC and ABC transporter families, facilitating systemic distribution to all tissues.

Within the cytoplasm and mitochondria, Thiamine ( B1) is phosphorylated to Thiamine Pyrophosphate ( TPP), a cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, linking glycolysis to the TCA cycle. Riboflavin ( B2) is converted to FAD and FMN, which function as electron acceptors in the Electron Transport Chain (ETC) complexes I and II. Niacinamide ( B3) is a precursor for NAD^+ and NADP^+, pivotal coenzymes for redox reactions in numerous catabolic and anabolic pathways. Pantothenic Acid ( B5) is incorporated into Coenzyme A ( CoA), essential for fatty acid and cholesterol synthesis/metabolism. Pyridoxine ( B6) is converted to Pyridoxal-5-Phosphate ( PLP), a cofactor for transaminases and decarboxylases involved in amino acid metabolism and neurotransmitter synthesis. Biotin ( B7) is a cofactor for carboxylases, including acetyl-CoA carboxylase. Folic Acid ( B9) and Cobalamin ( B12) function in the one-carbon transfer pathway, critical for DNA synthesis and methylation reactions. Ascorbic Acid ( Vitamin C) acts as a soluble antioxidant and a cofactor for hydroxylase enzymes, modifying protein structure. This coordinated action modulates intermediary metabolism and cellular bioenergetics across multiple organ systems.

Dosage and Administration Information

The administration of Soluvit N is strictly limited to the intravenous infusion route, reflecting its designated use as an additive in Total Parenteral Nutrition (TPN) regimens. The product, supplied as a lyophilised powder, must not be administered undiluted and requires specific preparation before use.

The powder in the single-dose vial must first be aseptically dissolved with a minimum of 10 mL of a suitable sterile diluent, such as Water for Injections or Glucose solution. This reconstituted solution is then added directly into the larger volume of the TPN admixture fluid before being infused.

The standard administration schedule is once daily, and the entire daily dosage is typically delivered by continuous infusion over a period of several hours. This method ensures a controlled, slow supply of the vitamins throughout the day. The duration of use is continuous for the full period the patient requires intravenous nutrition.

Standard Dosing Regimens

Patient Population	Recommended Daily Dosage
Adults and Children ge 10 kg	The content of one vial daily
Infants and Children < 10 kg	1/10 of a vial per kg of body weight per day

For practical handling, if the final IV admixture is an aqueous solution, it should be protected from light during the infusion process. Dosing guidelines are fixed for adults and larger children, while requiring a weight-based calculation for infants and children under 10 kg.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Soluvit N

Evidence for Use in Total Intravenous Nutrition

Research examining Soluvit N, or comparable multivitamin preparations, was evaluated in the context of Parenteral Nutritional (IV) support for patients whose nutritional needs are met through intravenous feeding. These studies examined patient populations receiving comprehensive IV feeding, often in critical care or surgical recovery settings. The research was studied for its impact on clinical metrics such as Intensive Care Unit (ICU) and Hospital Length of Stay (LOS), duration of mechanical ventilation, and survival. Findings were mixed regarding these complex outcomes, and data showed patterns related to the overall nutritional strategy rather than isolating the multivitamin component itself.

Studies Tracking Vitamin Levels (Biomarkers)

Research focusing on the supplement’s role was evaluated in Prospective Open-Label Studies where patients receiving intravenous nutrition was observed over defined time intervals. The key outcomes monitoring physiological strain or stress were the actual plasma and blood cell concentrations of the B-complex group and Vitamin C. These studies consistently reported that providing the vitamins through the parenteral route results in measured blood concentrations of these nutrients. The data show patterns related to maintaining the vitamin status in observed patient groups, contributing to the broader evidence landscape.

Evidence in Special Populations

The evidence base was evaluated in a variety of patient groups, including Adults who are critically ill and pediatric patients, including infants and neonates, who require total nutritional support. Findings related to nutrient status in these groups was observed across a broad age range. However, evidence quality varies across studies, and data for certain groups remain insufficient. Subgroup findings are uncertain when trying to define precise differences in nutrient status.

What is Still Uncertain About Soluvit N Research

Certainty remains low when research examines the multivitamin supplement's association with outcomes like mortality or hospital stay, as evidence is limited to the overarching nutritional strategy. Research results are commonly extrapolated from trials evaluating the need for TPN itself or the use of single-vitamin components. Furthermore, comparative evidence is lacking between different formulations or against a true placebo (no vitamins). Evidence highlights what is known—that the product was observed in supplying the necessary vitamins—and what is still uncertain—its direct, isolated impact on major clinical outcomes over the long term.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Soluvit N (FAQ)

Q: How quickly does Soluvit N start to have an effect?

A: Official documents state that when the solution is infused intravenously, the water-soluble vitamins are handled by the body in a way similar to vitamins obtained from an oral diet. The product is intended to maintain or restore the body’s vitamin balance and does not have an immediate or separate drug-like effect.

Q: Does Soluvit N interact with blood thinners?

A: Regulatory documents list specific drug-to-drug interactions for certain components, such as Folic acid and Phenytoin. However, official product information does not list interactions with the general class of blood thinners (anticoagulants).

Q: Can Soluvit N be given at home?

A: According to regulatory information, Soluvit N is administered by a healthcare professional and is typically used in a hospital or clinical setting as part of an intravenous nutrition regimen. It is reserved for specialized parenteral use.

Q: Is there a maximum duration for Soluvit N treatment?

A: Official documentation indicates that the duration of use is generally continuous for the full period the patient requires intravenous nutrition, as determined by their healthcare professional. A predetermined maximum duration in days or weeks is not specified in the labeling.

Q: Has there been much research on the long-term use of Soluvit N?

A: Safety evaluation is based mainly on clinical experience and long-standing documentation. For long-term Total Parenteral Nutrition (TPN) that lasts for months or years, official warnings state that periodic monitoring of blood vitamin levels may be applicable.

Q: Why are the vitamins in Soluvit N formulated as a powder for solution?

A: The drug is supplied as a lyophilised (freeze-dried) powder for solution for infusion. This specialized form is designed to contribute to the product’s documented shelf life when it is stored unopened.

Q: Is Soluvit N often used after surgery?

A: The product is indicated for patients who require intravenous nutrition, a group that includes people under physical stress from illness or recent surgery.

Q: Why is Soluvit N sometimes combined with fat emulsions?

A: Official documents state that when the admixture is diluted with water-based solutions, it must be protected from light. Combining with certain fat emulsions is noted as potentially providing a protective effect against light.

Q: Is there a risk of building up too much of a vitamin from Soluvit N?

A: Yes, official regulatory documents list hypervitaminosis (excessive amounts of vitamins) of any component as a stated condition that requires restrictions on use.

Q: What are the ingredients in Soluvit N besides the vitamins?

A: In addition to the nine water-soluble vitamins, official excipient lists include substances such as Glycine, Sodium edetate, and the preservative Methyl hydroxybenzoate.

Q: Is Soluvit N used for general wellness or only for deficiencies?

A: The product is intended to meet daily maintenance requirements of water-soluble vitamins during intravenous nutrition. Official warnings state that the recommended doses are insufficient to correct severe pre-existing vitamin deficiency states.

Q: Is Soluvit N safe for people with kidney issues?

A: Official warnings state that use requires caution in patients with renal impairment (kidney issues). This is primarily due to the potential for the biotin component to interfere with certain clinical laboratory tests.

Q: Does Soluvit N contain any preservatives?

A: Yes, official sources list Methyl hydroxybenzoate as a preservative (excipient) in the formulation.

Q: Is Soluvit N the same as other multivitamin products?

A: Soluvit N is distinguished by its specific use and formulation. It is indicated as a supplement in intravenous nutrition to meet daily requirements, making it fundamentally different from oral or non-parenteral multivitamin products.

Q: Can Soluvit N cause changes in urine color?

A: Official documents do not list this as a specific adverse event. However, the product contains B vitamins, and physiological information notes that excess water-soluble vitamins are naturally excreted in the urine.

Q: What should I do if I think I missed a dose of Soluvit N?

A: Regulatory documents confirm that the product is administered under the care of a trained health care professional in a clinical setting. Questions regarding the infusion schedule or a missed dose are handled by the healthcare professional managing the infusion schedule.

Q: Does Soluvit N contain Vitamin K?

A: The official composition lists nine water-soluble vitamins but does not list Vitamin K, which is a fat-soluble vitamin, as an active ingredient. Fat-soluble vitamins are generally administered separately.

Q: What is the difference between Soluvit N and other vitamin B complex injections?

A: Soluvit N is formulated as a parenteral solution containing the B-complex group plus Vitamin C. It is specifically indicated and designed as a component of comprehensive intravenous nutrition.

Q: Does Soluvit N help with nerve problems?

A: The product is indicated for nutritional maintenance, and official documents do not claim that it helps with nerve problems. However, warnings state that the optic nerve may be affected in individuals receiving very high doses of cyanocobalamin (Vitamin B12, a component).

Q: Is Soluvit N considered a high-dose vitamin treatment?

A: Official warnings state that the recommended doses are insufficient to correct severe vitamin deficiency states. The product is instead designed to be a daily maintenance supplement.

Q: What is the intended duration of action for the vitamins in Soluvit N?

A: Pharmacokinetic information states that once the vitamins are in the body, their metabolism is rapid, and any excess is quickly excreted in the urine.

Q: Is Soluvit N a prescription-only medicine?

A: Yes, official sources, such as the DailyMed product type classification, list Soluvit N as a HUMAN PRESCRIPTION DRUG.

Q: Can Soluvit N affect sleep patterns?

A: Official documents list potential Central Nervous System (CNS) reactions such as headache and dizziness (frequency not known) as possible adverse effects, though a specific effect on sleep is not listed.

Q: Does Soluvit N contain sugar or gluten?

A: Official excipient lists do not mention gluten. The lists include Glycine and other components, but sugar is only introduced if a Glucose solution for infusion is used as the sterile diluent.

Q: Who is responsible for preparing and administering Soluvit N?

A: The product is for specialized use and must be prepared and administered by a healthcare professional in a hospital or clinic setting.

Q: Are there specific symptoms that indicate a need for Soluvit N?

A: The product is not indicated based on external symptoms alone. It is indicated to meet the daily requirements of water-soluble vitamins in patients requiring intravenous nutrition (TPN).

Q: Does the color of the Soluvit N solution matter?

A: The powder for solution is officially described as a lyophilised, sterile, yellow mixture of water-soluble vitamins. The color is described in official product information as a quality attribute.

Q: Can Soluvit N be used in people with certain liver diseases?

A: Official warnings advise caution in patients with impaired biliary (bile duct) and/or renal (kidney) function. This caution is due to the decreased rate of excretion that may lead to the accumulation of certain components.

How should Soluvit N be stored and disposed of?

How to Store and Dispose of Soluvit N

Storage and disposal requirements for Soluvit N are strictly defined to ensure product integrity and safety.

Storage Requirements

Condition	Requirement
Temperature	Store the unopened vial below 25 C. Do not freeze.
Protection	Protect the powder and the reconstituted solution from light.
Handling	The vial is for SINGLE USE only. Keep out of the reach of children.

Stability and Disposal

Once the powder is reconstituted, the solution is microbiologically stable for 24 hours at 25 C; however, immediate use is preferred. Any unused portion of the vial and any expired Soluvit N product must be discarded. Disposal should be carried out in accordance with all applicable local, regulated pharmaceutical waste requirements.

Soluvit N